Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval
November 28, 2023
Webinar
Strafford Publications
As part of the Strafford Publications’ virtual programming, Finnegan attorney Yieyie Yang will discuss recently released FDA draft guidance helping to clarify the application process for approval of biosimilar and interchangeable biosimilar products. The panel will also explain how guidance differs from the past and ways it impacts the current application process and developmental strategies. For more information, or to register, please see Strafford’s website.
